These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24168985)

  • 1. Delayed start of diphtheria, tetanus, acellular pertussis and inactivated polio vaccination in preterm and low birth weight infants in the Netherlands.
    Woestenberg PJ; van Lier A; van der Maas NA; Drijfhout IH; Oomen PJ; de Melker HE
    Pediatr Infect Dis J; 2014 Feb; 33(2):190-8. PubMed ID: 24168985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
    Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Romero A; Lopez G; Dal-Ré R
    Pediatrics; 2005 Dec; 116(6):1292-8. PubMed ID: 16322149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population.
    Batra JS; Eriksen EM; Zangwill KM; Lee M; Marcy SM; Ward JI;
    Pediatrics; 2009 Mar; 123(3):951-8. PubMed ID: 19255025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study.
    Carbone T; McEntire B; Kissin D; Kelly D; Steinschneider A; Violaris K; Karamchandani N
    Pediatrics; 2008 May; 121(5):e1085-90. PubMed ID: 18450851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.
    Omeñaca F; Arístegui J; Tejedor JC; Moreno-Perez D; Ruiz-Contreras J; Merino JM; Muro Brussi M; Sánchez-Tamayo T; Castro Fernandez J; Cabanillas L; Peddiraju K; Mesaros N; Miller JM
    Pediatr Infect Dis J; 2011 Nov; 30(11):e216-24. PubMed ID: 21747321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dutch national immunization schedule: compliance and associated characteristics for the primary series.
    Scheepers ED; van Lier A; Drijfhout IH; Berbers G; van der Maas NAT; de Melker HE; Knol MJ
    Eur J Pediatr; 2017 Jun; 176(6):769-778. PubMed ID: 28429116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination timeliness and completeness among preterm and low birthweight infants: a national cohort study.
    Bary-Weisberg D; Stein-Zamir C
    Hum Vaccin Immunother; 2021 Jun; 17(6):1666-1674. PubMed ID: 33325771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: results of the ACTION follow-up project.
    Tozzi AE; Piga S; Corchia C; Di Lallo D; Carnielli V; Chiandotto V; Fertz MC; Miniaci S; Rusconi F; Cuttini M
    Vaccine; 2014 Feb; 32(7):793-9. PubMed ID: 24397902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis in infants under one year old: risk markers and vaccination status--a case-control study.
    Zamir CS; Dahan DB; Shoob H
    Vaccine; 2015 Apr; 33(17):2073-8. PubMed ID: 25728322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.
    Wood N; McIntyre P; Marshall H; Roberton D
    Pediatr Infect Dis J; 2010 Mar; 29(3):209-15. PubMed ID: 20009964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timeliness of immunisations in preterm infants in the Netherlands.
    Rouers EDM; Berbers GAM; van Dongen JAP; Sanders EAM; Bruijning-Verhagen P;
    Vaccine; 2019 Sep; 37(39):5862-5867. PubMed ID: 31443994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphtheria, pertussis, poliomyelitis, tetanus, and Haemophilus influenzae type b vaccinations and risk of eczema and recurrent wheeze in the first year of life: the KOALA Birth Cohort Study.
    Kummeling I; Thijs C; Stelma F; Huber M; van den Brandt PA; Dagnelie PC
    Pediatrics; 2007 Feb; 119(2):e367-73. PubMed ID: 17272598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of DTaP-IPV-HB vaccine on use of health services for young infants.
    Thompson LA; Irigoyen M; Matiz LA; LaRussa PS; Chen S; Chimkin F
    Pediatr Infect Dis J; 2006 Sep; 25(9):826-31. PubMed ID: 16940842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely.
    Omeñaca F; Garcia-Sicilia J; Boceta R; Sistiaga-Hernando A; García-Corbeira P
    Pediatr Infect Dis J; 2007 Sep; 26(9):824-9. PubMed ID: 17721379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.